Eugia US recalls

Eugia US has 17 recalls on record with the FDA and USDA, the earliest in 2023 and the latest reported on 10 Jun 2026. 16 are still ongoing. 1 was reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls17since 2023

Last 12 months1reported

Class I16% of total

Ongoing16latest 10 Jun 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 2 0Feb 0 1 2May 1 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 1 0 0Aug 0 0

Severity split

Class I 1 6%Class II 14 82%Class III 2 12%

Why eugia us is recalled

Product types

Injectable & IV Drugs1694%
Pain Medication16%

Brands

By year

202616%
2025635%
2024847%
2023212%

Ongoing eugia us recalls

16 active

Reported	Class	Recall	Company	Reason	Where
10 Jun 2026Drug	CLASS III	Lidocaine HCl Injection, USP 2%, 40 mg recalled by Eugia USLidolog Kit	Eugia US	Other	Nationwide
25 Jun 2025Drug	CLASS II	Gentamicin Injection, USP, (Pediatric), 20 mg recalled by Eugia USGentamicin	Eugia US	Potency & Assay	Nationwide
7 May 2025Drug	CLASS II	Tirofiban Hydrochloride Injection 5 mg recalled by Eugia USTirofiban	Eugia US	Potency & Assay	Nationwide
7 May 2025Drug	CLASS II	Tirofiban Hydrochloride Injection 12.5 mg recalled by Eugia USTirofiban	Eugia US	Potency & Assay	Nationwide
23 Apr 2025Drug	CLASS II	Testosterone Cypionate Injection, USP, CIII, 200mg per mL recalledTestosterone Cypionate	Eugia US	Manufacturing (CGMP) Deviations	Nationwide
15 Jan 2025Drug	CLASS II	medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL recalledMedroxyprogesterone Acetate	Eugia US	Manufacturing (CGMP) Deviations	Nationwide

All eugia us recalls, newest first

17 total

Reported	Class	Recall	Company	Reason	Where
10 Jun 2026Drug	CLASS III	Lidocaine HCl Injection, USP 2%, 40 mg recalled by Eugia USLidolog Kit	Eugia US	Other	Nationwide
25 Jun 2025Drug	CLASS II	Gentamicin Injection, USP, (Pediatric), 20 mg recalled by Eugia USGentamicin	Eugia US	Potency & Assay	Nationwide
7 May 2025Drug	CLASS II	Tirofiban Hydrochloride Injection 5 mg recalled by Eugia USTirofiban	Eugia US	Potency & Assay	Nationwide
7 May 2025Drug	CLASS II	Tirofiban Hydrochloride Injection 12.5 mg recalled by Eugia USTirofiban	Eugia US	Potency & Assay	Nationwide
23 Apr 2025Drug	CLASS II	Testosterone Cypionate Injection, USP, CIII, 200mg per mL recalledTestosterone Cypionate	Eugia US	Manufacturing (CGMP) Deviations	Nationwide
15 Jan 2025Drug	CLASS II	medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL recalledMedroxyprogesterone Acetate	Eugia US	Manufacturing (CGMP) Deviations	Nationwide
15 Jan 2025Drug	CLASS II	Progesterone Injection USP, 500mg per (50mg/mL) Multiple Dose Vial recalledProgesterone	Eugia US	Particulate Matter	Nationwide
7 Aug 2024Drug	CLASS II	Progesterone Injection, USP, 500 mg per (50mg/mL) Multiple-Dose Vial recalledProgesterone	Eugia US	Particulate Matter	Nationwide
26 Jun 2024Drug	CLASS III	Eptifibatide injection 20mg/ (2mg/mL) Single-Dose Vial recalledEptifibatide	Eugia US	Potency & Assay	Nationwide
26 Jun 2024Drug	CLASS II	Dexamethasone Sodium Phosphate injection USP, 120mg recalled by Eugia USDexamethasone Sodium Phosphate	Eugia US	Potency & Assay	Nationwide
17 Apr 2024Drug	CLASS I	Methocarbamol Injection, USP 1000mg recalled by Eugia USMethocarbamol	Eugia US	Particulate Matter	Nationwide
27 Mar 2024Drug	CLASS II	Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per Vial recalledNicardipine Hydrochloride	Eugia US	Potency & Assay	Nationwide
27 Mar 2024Drug	CLASS II	Nicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) vials recalledNicardipine Hydrochloride	Eugia US	Potency & Assay	Nationwide
20 Mar 2024Drug	CLASS II	Tobramycin for Injection, USP per Pharmacy recalled by Eugia USTobramycin	Eugia US	Potency & Assay	Nationwide
13 Mar 2024Drug	CLASS II	Methylprednisolone acetate Injectable Suspension recalled by Eugia USMethylprednisolone Acetate	Eugia US	Potency & Assay	4 states
11 Oct 2023Drug	CLASS II	Triamcinolone Acetonide Injectable Suspension recalled by Eugia USTriamcinolone Acetonide	Eugia US	Particulate Matter	Nationwide
11 Jan 2023Drug	CLASS II	Acyclovir Sodium Injection 1,000 mg per* (50 mg/mL) recalled by Eugia USAcyclovir Sodium	Eugia US	Particulate Matter	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.